FCGR2A and Autoimmunity: To provide a mechanistic explanation for the clinical importance of rituximab-FcγR engagement, we aimed to assess association of FcγR allotypes on B-cell depletion, clinical response and ex vivo NK-cell-mediated killing with a view to informing personalised B-cell depleting therapies in autoimmunity.